Sign In
Buy NMTC
$1.69
-0.0100 (-0.588%)
At Close: Jul 31, 2026
NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation
09:30am, Thursday, 20'th Jun 2024
ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024
NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript
09:48pm, Tuesday, 14'th May 2024
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Dave Rosa - President & Chief Executive Officer Ron McClurg - Chi
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
04:00pm, Tuesday, 14'th May 2024
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
02:43pm, Friday, 10'th May 2024
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
09:00am, Wednesday, 10'th Apr 2024
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improvin
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
09:05am, Tuesday, 09'th Apr 2024
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control
NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.
09:00am, Thursday, 04'th Apr 2024
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improvin
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
09:00am, Tuesday, 26'th Mar 2024
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control
NeuroOne® to Participate in the 36th Annual Roth Conference
12:00pm, Friday, 08'th Mar 2024
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:10pm, Friday, 23'rd Feb 2024
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript
08:04pm, Tuesday, 13'th Feb 2024
NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
04:00pm, Tuesday, 13'th Feb 2024
EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
03:30pm, Thursday, 08'th Feb 2024
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne Medical Technologies Corporation (NMTC) Q4 2023 Earnings Call Transcript
06:30pm, Thursday, 14'th Dec 2023
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q4 2023 Results Conference Call December 14, 2023 5:00 PM ET Company Participants Dave Rosa - CEO Ron McClurg - CFO Conference Call Participant
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
04:15pm, Thursday, 14'th Dec 2023
EDEN PRAIRIE, Minn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
